CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-30 | Elia Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +10,700,000 | 10,700,000 | ||
| 2026-05-19 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-20 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-21 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-05-23 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-08-19 | Elia Marc Director | Purchase | +584,451 | $4.62 | $2.7M | 9,248,250 |
| 2022-08-18 | Elia Marc Director | Purchase | +1,265,549 | $4.31 | $5.5M | 8,663,799 |
| 2022-08-17 | Elia Marc Director | Purchase | +1,000,000 | $4.04 | $4.0M | 7,398,250 |
| 2022-06-22 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 1 of 1 · 9 trades